AHCO official logo AHCO
AHCO 1-star rating from Upturn Advisory
Adapthealth Corp (AHCO) company logo

Adapthealth Corp (AHCO)

Adapthealth Corp (AHCO) 1-star rating from Upturn Advisory
$10.27
Last Close (24-hour delay)
Profit since last BUY0.2%
upturn advisory logo
Consider higher Upturn Star rating
BUY since 3 days
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock price based on last close icon Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

12/15/2025: AHCO (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

Upturn 1 star rating for performance

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

2 star rating from financial analysts

8 Analysts rated it

Limited analyst coverage, niche firm, research info may be scarce.

1 Year Target Price $13.25

1 Year Target Price $13.25

Analysts Price Target For last 52 week
$13.25 Target price
52w Low $7.11
Current$10.27
52w High $11.63

Analysis of Past Performance

Type Stock
Historic Profit -76.16%
Avg. Invested days 19
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 1.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 12/15/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 1.41B USD
Price to earnings Ratio 18.91
1Y Target Price 13.25
Price to earnings Ratio 18.91
1Y Target Price 13.25
Volume (30-day avg) 8
Beta 1.77
52 Weeks Range 7.11 - 11.63
Updated Date 12/14/2025
52 Weeks Range 7.11 - 11.63
Updated Date 12/14/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.55

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 2.53%
Operating Margin (TTM) 8.18%

Management Effectiveness

Return on Assets (TTM) 3.64%
Return on Equity (TTM) 5.52%

Valuation

Trailing PE 18.91
Forward PE 8.94
Enterprise Value 3231996073
Price to Sales(TTM) 0.43
Enterprise Value 3231996073
Price to Sales(TTM) 0.43
Enterprise Value to Revenue 0.99
Enterprise Value to EBITDA 5.05
Shares Outstanding 135424334
Shares Floating 88019266
Shares Outstanding 135424334
Shares Floating 88019266
Percent Insiders 8.12
Percent Institutions 104.06

About Adapthealth Corp

Exchange NASDAQ
Headquaters Plymouth Meeting, PA, United States
IPO Launch date 2018-05-24
CEO & Director Ms. Suzanne M. Foster M.P.H.
Sector Healthcare
Industry Medical Devices
Full time employees 10500
Full time employees 10500

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.